Vital Biopharmaceutical Insights and Analytics

Decision Resources is the premier provider of analysis and data on the significant issues facing the biopharmaceutical industry.

Learn More

Featured Service
Irritable Bowel Syndrome

The irritable bowel syndrome drug market will more than triple from $459 million in 2008 to $1.52 billion in 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan ...Learn More

Featured Webinar
Will the Lack of Efficacious Therapies Open the Door for a New Clinical Gold Standard in Obesity Treatment?

March 17, 2010...Learn More

View Webinar schedule and archive

Search Reports

Filter results:

TOP TEN REPORTS

See which reports have been searched on the most.

In the Spotlight

Thursday, April 8, 2010
Basking Ridge, NJ
9 a.m. to 3 p.m. ET

Join us for our complimentary DecisionBase 2010 one-day seminar. To reserve your place, please register by March 24, 2010. Click here to view the agenda and learn more.

Latest Press Releases [ view all ]

March 15, 2010

A Stage IV Colorectal Cancer Therapy That Improves Median Overall Survival Over IFL/Bevacizumab Would Earn a 60 Percent Patient Share in the United States, According to Surveyed Oncologists ...Read More
March 15, 2010

The Irritable Bowel Syndrome Drug Market Will More Than Triple From $459 Million in 2008 to $1.52 Billion in 2018 ...Read More
March 11, 2010

Stimuvax Will Become Decision Resources’ Proprietary Clinical Gold Standard for the Treatment of Locally Advanced Non-Small-Cell Lung Cancer ...Read More

Recent Reports [ view all ]

Licensing Opportunities: Cancer Vaccines

Is high-risk development of therapeutic cancer vaccines a good opportunity for pharmaceutical companies? In 2009,... Read More
Hepatitis C Virus (Treatment-Naive Patients): Triple- and Quadruple-Therapy Regimens Vying for Patient Share of a Diminishing Patient Population

Therapies currently available for treatment-naive hepatitis C virus (HCV) patients have less than optimal efficacy—only... Read More
Human Immunodeficiency Virus (HIV) (Event Driven)

Last Updated 15 March 2010
The HIV market is highly dynamic, with one of the most active pipelines,... Read More